YB
Yebeen Ysabelle Boo
Novartis (UK), AstraZeneca (United Kingdom), University of Oxford, University College London, London Borough of Hackney
Research areas: Medicine · Pediatrics, Perinatology and Child Health · Health Policy Implementation Science · Global Maternal and Child Health · Asthma and respiratory diseases
0000-0003-2557-0678
Employment
-
Novartis (UK) Associate Director Biostatistics RWD2026 - Present
-
AstraZeneca (United Kingdom) Real World Evidence Manager2024 - 2026
- 2023 - 2024
-
Innovex Partners2023 - 2024
-
Aceso Global Health Consultants Ltd2019 - 2022
Education
-
University of Oxford DPhil Population Health2021 - 2025
-
University College London BSc Population Health, Data science pathway2017 - 2020
Projects & Funding
-
Clarendon Fund Clarendon Fund2021 - 2024
-
Nuffield Department of Population Health Scholarship University of Oxford2021 - 2024
-
Kellogg College Scholarship University of Oxford2021 - 2024
-
Mogam Science Scholarship Mogan Science Scholarship Foundation, GC Pharma (GC녹십자)2020 - Present
-
Nuffield Department of Population Health Bursary University Of Oxford2020 - 2021
Publications (14)
- Risk factors for intrapartum stillbirth and the survival probabilities of fetuses among pregnant women with complications: Secondary analysis of data from a multicenter prospective cohort study in India Save
- Facilitators and barriers to implementing and sustaining facility-based stillbirth reviews in India: a qualitative study Save
- Access to dental care and caries experience among children with cerebral palsy: a Singapore experience Save
- Maternal and fetal factors associated with stillbirth in singleton pregnancies in 13 hospitals across six states in India: A prospective cohort study Save
- Developing an evidence-based, comprehensive model for a facility-based stillbirth review process in India: a mixed methods study Save
- Facility-based stillbirth review processes used in different countries across the world: a systematic review Save
- Key considerations when involving children in health intervention design: reflections on working in partnership with South Asian children in the UK on a tailored Management and Intervention for Asthma (MIA) study Save
- Facility-Based Stillbirth Review Processes Used in Different Countries Across the World: A Systematic Review Save
- What are the determinants of childhood infections in India’s peri-urban slums? A case study of eight cities Save
- The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA) Save
- A structured collaborative approach to intervention design using a modified intervention mapping approach: a case study using the Management and Interventions for Asthma (MIA) project for South Asian children Save
- Operationalising a One Health approach to reduce the infection and antimicrobial resistance (AMR) burden in under-5 year old urban slum dwellers: The Childhood Infections and Pollution (CHIP) Consortium Save
- Risk assessment of mass gathering to control COVID-19 outbreak: Viewpoints (Preprint) Save
- Economic impact of Ebola virus disease outbreak on an extractive firm: a case study Save